ResearchAndMarkets forecasts proteomic biomarker analytics to grow 10-15% annually, driven by cancer diagnostics and drug ...

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, ...

FFPE proteomics workflow that enables rapid, high-throughput spatial proteomics of laser-capture microdissected tissue. Systematic proteomic profiling uncovered mechanisms driving drug toxicity ...

Proteomic analysis identifies a 26-protein signature of continued ovarian remodeling across the decades following menopause.

Glint’s new proteomics technology enables fast and sensitive protein biomarker detection at a fraction of the cost of ...

Proteomics technology platform company Bertis announced on the 15th that it had been selected for the Specialized Scale-Up ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, ...

A study of ovarian tissue from 28 postmenopausal women found that the organ keeps changing at the molecular level for decades ...

A University of Queensland study has outlined a practical pathway for accelerating the development of heat-adapted chickpeas ...

The 2026 Best Video Award, recognizing cohort companies' excellence in effectively and creatively communicating their value proposition in a short video format, was also presented during the Capstone ...

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI,” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has ...

Blood protein signatures could help distinguish primary biliary cholangitis from MASLD and healthy individuals.